HOME › Research Insight › Significantly Change the Competitive Landscape of the Global Genomics Market
Significantly Change the Competitive Landscape of the Global Genomics Market
The Global Genomics market was valued at an estimated $11.11 billion in 2013 and is poised to grow at a CAGR of more than 10% during the forecast period.In 2013, over 60% of the global genomics market was dominated by Tier I players such as Roche Diagnostics, Life Technologies, QIAGEN, Illumina, and Bio-Rad. Roche Diagnostics was the market leader in the global genomics market in 2013. This may be attributed to its strategic integration with NimbleGenís MS 200 microarray scanner, as well as its co-promotional agreement with SoftGenetics in 2012. Significant Tier II players include BGI, PerkinElmer, and Hologic Gen-Probe, and Tier III companies included Oxford Gene Technology, Knome, and Phalanx Biotech. Notable tier IV players in this market wereLGC Genomics and DNA STAR.
The Global Genomics market was found to be increasingly consolidated, owing to various restructuring activities in the past five years. Tier I and Tier II companies were the key acquirers, while Tier III companies were found to be the targets of M&A activities. Besides mergers and acquisitions, alliances were also a prominent strategy amongst leading players. Technology licensing was the most prevalent motive of such alliances. The acquisition of Life Technologies by Thermo Fischer in 2014 is expected to significantly change the competitive landscape of the global genomics market, as two key players in this market merge to consolidate Thermo Fischerís market shares in coming years.The Instrument and Consumables product segments were dominated by companies with a global presence, while the Services market was dominated by small to medium-scale service providers with a regional presence.
PCR technology accounted for the largest revenue share of the global genomics technology market, while NGS technology was found to be the most promising technology amongst the technology sub segments in the DNA sequencing technology segment, in terms of revenue.Thus, PCR and NGS technologies represent the key playing fields for market players, to gain market shares. In terms of application areas, the key growth area remains the diagnostics segment, with personalized medicine applications set to grow significantly during the forecast period.
Genomics Market by Products- Instruments [NGS platform, Microarray, RT-PCR], Consumables [Genechips, Reagents for DNA Extraction & Purification, Sequencing], Services [Sequencing & Microarray Services, and Software] - Global Forecast to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252